Use of genome-wide association studies for drug repositioning
Year: 2012
Type: article
Source: Nature Biotechnology
DOI: 10.1038/nbt.2151
Institutions: GlaxoSmithKline (United Kingdom), Queen Mary University of London, Centre Hospitalier Universitaire Vaudois, Hôpital Orthopédique de la Suisse Romande, William Harvey Research Institute, McGill University and Génome Québec Innovation Centre, McGill University, Jewish General Hospital, Lady Davis Institute for Medical Research, GlaxoSmithKline (United States)
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1982945330
